{
    "title": "Vir Biotech to begin mid-to-late stage study of COVID-19 drug candidate in August",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8617323/Vir-Biotech-begin-mid-late-stage-study-COVID-19-drug-candidate-August.html",
    "date": "2020-08-11",
    "keywords": [
        "drug",
        "candidate",
        "antibody",
        "biotech",
        "covid19",
        "biotechnology",
        "inc",
        "tuesday",
        "midtolate",
        "stage",
        "trial",
        "august",
        "globe",
        "rush",
        "companys",
        "therapy",
        "vir7831",
        "sarscov2",
        "virus",
        "study",
        "end",
        "vaccine",
        "monday",
        "application",
        "food",
        "administration",
        "approval",
        "remdesivir",
        "vir",
        "development",
        "vir2703",
        "vir7832",
        "year",
        "company",
        "investment",
        "drugmaker",
        "glaxosmithkline",
        "plc",
        "march",
        "part",
        "collaboration",
        "reporting",
        "roy",
        "bengaluru",
        "editing",
        "syamnath"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}